PTN11_HUMAN - dbPTM
PTN11_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PTN11_HUMAN
UniProt AC Q06124
Protein Name Tyrosine-protein phosphatase non-receptor type 11
Gene Name PTPN11
Organism Homo sapiens (Human).
Sequence Length 597
Subcellular Localization Cytoplasm . Nucleus .
Protein Description Acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus. Positively regulates MAPK signal transduction pathway. [PubMed: 28074573 Dephosphorylates GAB1, ARHGAP35 and EGFR]
Protein Sequence MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQALLQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKGHEYTNIKYSLADQTSGDQSPLPPCTPTPPCAEMREDSARVYENVGLMQQQKSFR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MTSRRWFHP
------CCCCCCCCC
30.8219413330
28PhosphorylationLTRGVDGSFLARPSK
EECCCCCCEECCCCC
16.7817855441
34PhosphorylationGSFLARPSKSNPGDF
CCEECCCCCCCCCCC
43.0723312004
35UbiquitinationSFLARPSKSNPGDFT
CEECCCCCCCCCCCE
57.8633845483
35MalonylationSFLARPSKSNPGDFT
CEECCCCCCCCCCCE
57.8626320211
36PhosphorylationFLARPSKSNPGDFTL
EECCCCCCCCCCCEE
53.2320873877
42PhosphorylationKSNPGDFTLSVRRNG
CCCCCCCEEEEEECC
23.9028270605
52PhosphorylationVRRNGAVTHIKIQNT
EEECCEEEEEEEEEC
19.8330576142
55AcetylationNGAVTHIKIQNTGDY
CCEEEEEEEEECCCE
30.5425953088
59PhosphorylationTHIKIQNTGDYYDLY
EEEEEEECCCEECCC
18.3023927012
62PhosphorylationKIQNTGDYYDLYGGE
EEEECCCEECCCCCC
10.5425159151
63PhosphorylationIQNTGDYYDLYGGEK
EEECCCEECCCCCCH
12.2927273156
66PhosphorylationTGDYYDLYGGEKFAT
CCCEECCCCCCHHHH
21.8623927012
73PhosphorylationYGGEKFATLAELVQY
CCCCHHHHHHHHHHH
29.63-
80PhosphorylationTLAELVQYYMEHHGQ
HHHHHHHHHHHHCCC
9.41-
82SulfoxidationAELVQYYMEHHGQLK
HHHHHHHHHHCCCCC
3.1730846556
91MalonylationHHGQLKEKNGDVIEL
HCCCCCHHCCCEEEE
65.7226320211
91AcetylationHHGQLKEKNGDVIEL
HCCCCCHHCCCEEEE
65.7225953088
99AcetylationNGDVIELKYPLNCAD
CCCEEEEEEECCCCC
31.8426051181
119UbiquitinationWFHGHLSGKEAEKLL
CCCCCCCHHHHHHHH
37.8832015554
120UbiquitinationFHGHLSGKEAEKLLT
CCCCCCHHHHHHHHH
50.8332015554
123UbiquitinationHLSGKEAEKLLTEKG
CCCHHHHHHHHHHCC
45.3833845483
124UbiquitinationLSGKEAEKLLTEKGK
CCHHHHHHHHHHCCC
56.7133845483
131UbiquitinationKLLTEKGKHGSFLVR
HHHHHCCCCCCEEEE
56.7229967540
131MalonylationKLLTEKGKHGSFLVR
HHHHHCCCCCCEEEE
56.7226320211
131AcetylationKLLTEKGKHGSFLVR
HHHHHCCCCCCEEEE
56.7225953088
140PhosphorylationGSFLVRESQSHPGDF
CCEEEEECCCCCCCE
26.8125159151
142PhosphorylationFLVRESQSHPGDFVL
EEEEECCCCCCCEEE
40.7125159151
153PhosphorylationDFVLSVRTGDDKGES
CEEEEEEECCCCCCC
42.69-
156UbiquitinationLSVRTGDDKGESNDG
EEEEECCCCCCCCCC
63.3024816145
157UbiquitinationSVRTGDDKGESNDGK
EEEECCCCCCCCCCC
70.1324816145
160PhosphorylationTGDDKGESNDGKSKV
ECCCCCCCCCCCCCE
49.2226552605
165PhosphorylationGESNDGKSKVTHVMI
CCCCCCCCCEEEEEE
37.5826552605
178AcetylationMIRCQELKYDVGGGE
EEEEEEEEEECCCCC
38.3626051181
179PhosphorylationIRCQELKYDVGGGER
EEEEEEEEECCCCCC
28.61-
189PhosphorylationGGGERFDSLTDLVEH
CCCCCCCCHHHHHHH
30.3823312004
191PhosphorylationGERFDSLTDLVEHYK
CCCCCCHHHHHHHHH
31.1023312004
197UbiquitinationLTDLVEHYKKNPMVE
HHHHHHHHHHCCHHH
15.3421890473
197PhosphorylationLTDLVEHYKKNPMVE
HHHHHHHHHHCCHHH
15.3423312004
198AcetylationTDLVEHYKKNPMVET
HHHHHHHHHCCHHHH
48.2423954790
198UbiquitinationTDLVEHYKKNPMVET
HHHHHHHHHCCHHHH
48.2421890473
198 (in isoform 1)Ubiquitination-48.2421890473
198 (in isoform 2)Ubiquitination-48.2421890473
198 (in isoform 3)Ubiquitination-48.2421890473
213AcetylationLGTVLQLKQPLNTTR
HHHHHHHCCCCCCCC
36.5925953088
228PhosphorylationINAAEIESRVRELSK
CCHHHHHHHHHHHHH
41.5621130716
234PhosphorylationESRVRELSKLAETTD
HHHHHHHHHHHHHCH
22.3729449344
235UbiquitinationSRVRELSKLAETTDK
HHHHHHHHHHHHCHH
65.4329967540
242UbiquitinationKLAETTDKVKQGFWE
HHHHHCHHHHHHHHH
49.6029967540
242AcetylationKLAETTDKVKQGFWE
HHHHHCHHHHHHHHH
49.6025953088
244UbiquitinationAETTDKVKQGFWEEF
HHHCHHHHHHHHHHH
50.9029967540
2442-HydroxyisobutyrylationAETTDKVKQGFWEEF
HHHCHHHHHHHHHHH
50.90-
260UbiquitinationTLQQQECKLLYSRKE
HHHHHHHHHHHHCHH
40.5529967540
263PhosphorylationQQECKLLYSRKEGQR
HHHHHHHHHCHHHHC
19.5020736484
264PhosphorylationQECKLLYSRKEGQRQ
HHHHHHHHCHHHHCH
36.5224719451
274AcetylationEGQRQENKNKNRYKN
HHHCHHCCCCCCCCC
69.4218526083
276AcetylationQRQENKNKNRYKNIL
HCHHCCCCCCCCCCC
44.4018526093
279PhosphorylationENKNKNRYKNILPFD
HCCCCCCCCCCCCCC
20.1318707149
280AcetylationNKNKNRYKNILPFDH
CCCCCCCCCCCCCCC
33.9819608861
280UbiquitinationNKNKNRYKNILPFDH
CCCCCCCCCCCCCCC
33.9829967540
280MalonylationNKNKNRYKNILPFDH
CCCCCCCCCCCCCCC
33.9826320211
302PhosphorylationGDPNEPVSDYINANI
CCCCCCHHHHCCCEE
35.1029978859
304PhosphorylationPNEPVSDYINANIIM
CCCCHHHHCCCEEEC
6.6425884760
316PhosphorylationIIMPEFETKCNNSKP
EECCCCCCCCCCCCC
46.3326552605
317UbiquitinationIMPEFETKCNNSKPK
ECCCCCCCCCCCCCC
27.9729967540
355SulfoxidationENSRVIVMTTKEVER
CCCEEEEEECCCHHC
2.4330846556
357UbiquitinationSRVIVMTTKEVERGK
CEEEEEECCCHHCCC
13.7024816145
358UbiquitinationRVIVMTTKEVERGKS
EEEEEECCCHHCCCC
51.0724816145
358AcetylationRVIVMTTKEVERGKS
EEEEEECCCHHCCCC
51.0726051181
370PhosphorylationGKSKCVKYWPDEYAL
CCCCCCCCCCCHHHH
11.1928270605
375PhosphorylationVKYWPDEYALKEYGV
CCCCCCHHHHHHHCC
25.3128270605
389UbiquitinationVMRVRNVKESAAHDY
CEEEECCCHHHHCCC
49.8829967540
3892-HydroxyisobutyrylationVMRVRNVKESAAHDY
CEEEECCCHHHHCCC
49.88-
397PhosphorylationESAAHDYTLRELKLS
HHHHCCCCHHHHCHH
25.9524719451
401UbiquitinationHDYTLRELKLSKVGQ
CCCCHHHHCHHHHHH
5.6727667366
402UbiquitinationDYTLRELKLSKVGQA
CCCHHHHCHHHHHHH
46.0627667366
415PhosphorylationQALLQGNTERTVWQY
HHHHCCCCCCEEEEE
33.4017855441
486AcetylationLIDIIREKGVDCDID
HHHHHHHHCCCCCCC
55.1523954790
486MalonylationLIDIIREKGVDCDID
HHHHHHHHCCCCCCC
55.1526320211
496AcetylationDCDIDVPKTIQMVRS
CCCCCCCHHHHHHHH
59.1026051181
496MalonylationDCDIDVPKTIQMVRS
CCCCCCCHHHHHHHH
59.1026320211
503PhosphorylationKTIQMVRSQRSGMVQ
HHHHHHHHCCCCCCC
20.6629438985
511PhosphorylationQRSGMVQTEAQYRFI
CCCCCCCCHHHHHHH
23.1329438985
515PhosphorylationMVQTEAQYRFIYMAV
CCCCHHHHHHHHHHH
17.9720090780
519PhosphorylationEAQYRFIYMAVQHYI
HHHHHHHHHHHHHHH
4.0223898821
535PhosphorylationTLQRRIEEEQKSKRK
HHHHHHHHHHHHHHC
64.4524719451
535UbiquitinationTLQRRIEEEQKSKRK
HHHHHHHHHHHHHHC
64.4524816145
536UbiquitinationLQRRIEEEQKSKRKG
HHHHHHHHHHHHHCC
50.9824816145
538UbiquitinationRRIEEEQKSKRKGHE
HHHHHHHHHHHCCCC
62.3129967540
539UbiquitinationRIEEEQKSKRKGHEY
HHHHHHHHHHCCCCC
37.0724816145
539PhosphorylationRIEEEQKSKRKGHEY
HHHHHHHHHHCCCCC
37.0724719451
540UbiquitinationIEEEQKSKRKGHEYT
HHHHHHHHHCCCCCC
66.2324816145
542PhosphorylationEEQKSKRKGHEYTNI
HHHHHHHCCCCCCCC
69.258041791
542UbiquitinationEEQKSKRKGHEYTNI
HHHHHHHCCCCCCCC
69.2529967540
546PhosphorylationSKRKGHEYTNIKYSL
HHHCCCCCCCCCEEE
10.2227273156
547PhosphorylationKRKGHEYTNIKYSLA
HHCCCCCCCCCEEEC
27.7327273156
551PhosphorylationHEYTNIKYSLADQTS
CCCCCCCEEECCCCC
12.7228122231
552PhosphorylationEYTNIKYSLADQTSG
CCCCCCEEECCCCCC
16.4525159151
557PhosphorylationKYSLADQTSGDQSPL
CEEECCCCCCCCCCC
34.9123401153
558PhosphorylationYSLADQTSGDQSPLP
EEECCCCCCCCCCCC
34.4430278072
561PhosphorylationADQTSGDQSPLPPCT
CCCCCCCCCCCCCCC
50.9332142685
562PhosphorylationDQTSGDQSPLPPCTP
CCCCCCCCCCCCCCC
32.8930278072
564PhosphorylationTSGDQSPLPPCTPTP
CCCCCCCCCCCCCCC
10.0224719451
566PhosphorylationGDQSPLPPCTPTPPC
CCCCCCCCCCCCCCC
42.1532142685
568PhosphorylationQSPLPPCTPTPPCAE
CCCCCCCCCCCCCHH
35.6525159151
568O-linked_GlycosylationQSPLPPCTPTPPCAE
CCCCCCCCCCCCCHH
35.65OGP
570PhosphorylationPLPPCTPTPPCAEMR
CCCCCCCCCCCHHHC
23.0125159151
570O-linked_GlycosylationPLPPCTPTPPCAEMR
CCCCCCCCCCCHHHC
23.01OGP
576PhosphorylationPTPPCAEMREDSARV
CCCCCHHHCCCHHHH
2.7911781100
580PhosphorylationCAEMREDSARVYENV
CHHHCCCHHHHHHHH
17.1421945579
584PhosphorylationREDSARVYENVGLMQ
CCCHHHHHHHHHHHH
9.0212634870
589UbiquitinationRVYENVGLMQQQKSF
HHHHHHHHHHHHHHC
2.1423000965
590SumoylationVYENVGLMQQQKSFR
HHHHHHHHHHHHHCC
2.51-
590SulfoxidationVYENVGLMQQQKSFR
HHHHHHHHHHHHHCC
2.5130846556
590UbiquitinationVYENVGLMQQQKSFR
HHHHHHHHHHHHHCC
2.5123000965
591PhosphorylationYENVGLMQQQKSFR-
HHHHHHHHHHHHCC-
47.8224719451
593UbiquitinationNVGLMQQQKSFR---
HHHHHHHHHHCC---
26.8623000965
594UbiquitinationVGLMQQQKSFR----
HHHHHHHHHCC----
47.4223000965
594AcetylationVGLMQQQKSFR----
HHHHHHHHHCC----
47.4225953088
595PhosphorylationGLMQQQKSFR-----
HHHHHHHHCC-----
23.1623401153

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
73TPhosphorylationKinasePRKACAP17612
GPS
73TPhosphorylationKinasePKACAP17612
PSP
189SPhosphorylationKinasePRKACAP17612
GPS
189SPhosphorylationKinasePKACAP17612
PSP
542YPhosphorylationKinaseALKQ9UM73
PSP
542YPhosphorylationKinasePDGFRBP09619
GPS
542YPhosphorylationKinasePDGFRBP05622
PSP
542YPhosphorylationKinasePDGFR-Uniprot
542YPhosphorylationKinaseFYNP06241
PSP
546YPhosphorylationKinaseFYNP06241
GPS
546YPhosphorylationKinaseALKQ9UM73
GPS
546YPhosphorylationKinasePDGFR-FAMILY-GPS
546YPhosphorylationKinasePDGFRBP05622
GPS
546YPhosphorylationKinasePGFRBP09619
PhosphoELM
576SPhosphorylationKinasePKCAP17252
PSP
576SPhosphorylationKinasePKCBP05771
PSP
576SPhosphorylationKinasePKCB ISO2P05771-2
PSP
576SPhosphorylationKinasePKCHP24723
PSP
580YPhosphorylationKinaseALKQ9UM73
PSP
580YPhosphorylationKinasePDGFR-Uniprot
580SPhosphorylationKinasePRKCHP24723
GPS
580SPhosphorylationKinasePRKCBP05771
GPS
580SPhosphorylationKinasePRKCAP17252
GPS
584YPhosphorylationKinasePDGFR-FAMILY-GPS
584YPhosphorylationKinaseALKQ9UM73
GPS
591SPhosphorylationKinasePKCHP24723
PSP
591SPhosphorylationKinasePKCB ISO2P05771-2
PSP
591SPhosphorylationKinasePKCBP05771
PSP
591SPhosphorylationKinasePKCAP17252
PSP
595SPhosphorylationKinasePRKCHP24723
GPS
595SPhosphorylationKinasePRKCBP05771
GPS
595SPhosphorylationKinasePRKCAP17252
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PTN11_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PTN11_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
STA5A_HUMANSTAT5Aphysical
10617656
STA5B_HUMANSTAT5Bphysical
10617656
CSF3R_HUMANCSF3Rphysical
9824671
JAK1_HUMANJAK1physical
8995399
JAK2_HUMANJAK2physical
8995399
SOCS3_HUMANSOCS3physical
12403768
JAK1_HUMANJAK1physical
12403768
PLCG2_HUMANPLCG2physical
12135708
GAB2_HUMANGAB2physical
12135708
IRS1_HUMANIRS1physical
8505282
GAB3_HUMANGAB3physical
11739737
IRS1_HUMANIRS1physical
9756938
KIT_HUMANKITphysical
7523381
LYAM2_HUMANSELEphysical
11602579
CAV1_HUMANCAV1physical
12176037
CADH5_HUMANCDH5physical
10681592
CTNB1_HUMANCTNNB1physical
10681592
GRB2_HUMANGRB2physical
10212213
PGFRB_HUMANPDGFRBphysical
7691811
FAK2_HUMANPTK2Bphysical
10880513
GHR_HUMANGHRphysical
10976913
SOS1_HUMANSOS1physical
9344843
GHR_HUMANGHRphysical
9632636
GRB2_HUMANGRB2physical
8702859
CEAM1_HUMANCEACAM1physical
9867848
INSR_HUMANINSRphysical
7493946
PTN11_HUMANPTPN11physical
9847309
CBL_HUMANCBLphysical
18519587
P85A_HUMANPIK3R1physical
9886492
FAK1_HUMANPTK2physical
21726809
PAF1_HUMANPAF1physical
21726809
CDC73_HUMANCDC73physical
21726809
LEO1_HUMANLEO1physical
21726809
CTR9_HUMANCTR9physical
21726809
RTF1_HUMANRTF1physical
21726809
WDR61_HUMANWDR61physical
21726809
KIT_HUMANKITphysical
12444928
SOCS3_HUMANSOCS3physical
10777583
SHIP1_HUMANINPP5Dphysical
11157475
CBL_HUMANCBLphysical
11157475
M3K5_HUMANMAP3K5physical
19287004
FAS_HUMANFASNphysical
23269672
RFWD2_HUMANRFWD2physical
23269672
IRS1_HUMANIRS1physical
11781100
SIG12_MOUSESiglecephysical
11171044
GAB2_HUMANGAB2physical
15356145
MTPN_HUMANMTPNphysical
22863883
RPIA_HUMANRPIAphysical
25416956
TRI32_HUMANTRIM32physical
25416956
GRB2_HUMANGRB2physical
7534299
LNX1_HUMANLNX1physical
25814554
TXNIP_HUMANTXNIPphysical
26527736
TXNIP_HUMANTXNIPphysical
26919541
GAB1_HUMANGAB1physical
14701753
DYN2_HUMANDNM2physical
21996738
PGFRA_HUMANPDGFRAphysical
21996738
PRP19_HUMANPRPF19physical
27213290
SHPS1_HUMANSIRPAphysical
10962556
P85A_HUMANPIK3R1physical
10962556
P85A_HUMANPIK3R1physical
11593409
ERBB4_HUMANERBB4physical
28065597
CTR9_HUMANCTR9physical
27880917
PAF1_HUMANPAF1physical
27880917
PTN11_HUMANPTPN11physical
27432908
PTN6_HUMANPTPN6physical
27432908
GAB1_HUMANGAB1physical
20473329
GRB2_HUMANGRB2physical
20473329
SHPS1_HUMANSIRPAphysical
20473329
ERBB2_HUMANERBB2physical
8959326
GRB2_HUMANGRB2physical
8959326
BEX1_HUMANBEX1physical
27229929
BEX2_HUMANBEX2physical
27229929
GO45_HUMANBLZF1physical
27229929
CI062_HUMANC9orf62physical
27229929
CTDS1_HUMANCTDSP1physical
27229929
DMRTC_HUMANDMRTC1physical
27229929
F71E1_HUMANFAM71E1physical
27229929
GOGA2_HUMANGOLGA2physical
27229929
T2AG_HUMANGTF2A2physical
27229929
NSUN5_HUMANNSUN5physical
27229929
ORML3_HUMANORMDL3physical
27229929
PKHA4_HUMANPLEKHA4physical
27229929
KCC1B_HUMANPNCKphysical
27229929
OBF1_HUMANPOU2AF1physical
27229929
MOG1_HUMANRANGRFphysical
27229929
SERF2_HUMANSERF2physical
27229929
PEDF_HUMANSERPINF1physical
27229929
SRS10_HUMANSRSF10physical
27229929
S38A1_HUMANSLC38A1physical
27229929
SARCO_HUMANSLNphysical
27229929
STAT1_HUMANSTAT1physical
27229929
TLK1_HUMANTLK1physical
27229929
TRI32_HUMANTRIM32physical
27229929
TRM2_HUMANTRMT2Bphysical
27229929
GAB2_HUMANGAB2physical
16371368
P85A_HUMANPIK3R1physical
16371368
GRB2_HUMANGRB2physical
16371368
SOS1_HUMANSOS1physical
16371368

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
151100LEOPARD syndrome 1 (LPRD1)
163950Noonan syndrome 1 (NS1)
607785Leukemia, juvenile myelomonocytic (JMML)
156250Metachondromatosis (MC)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PTN11_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-280, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-562, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-584 AND SER-595, ANDMASS SPECTROMETRY.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62 AND TYR-584, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62; TYR-63 AND TYR-584,AND MASS SPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62; TYR-63 AND TYR-584,AND MASS SPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-584, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62, AND MASSSPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62, AND MASSSPECTROMETRY.

TOP